AMY COY: Open Payments
NPI 1326564048 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 46 payments from 11 companies in 2025. Trend: 2023 $922 · 2024 $573 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $218 |
| Novo Nordisk Inc | 12 | $180 |
| Exact Sciences Corporation | 6 | $90 |
| Lundbeck LLC | 2 | $40 |
| Biogen, Inc. | 1 | $25 |
| Lilly USA, LLC | 2 | $24 |
| Insulet Corporation | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: VRAYLAR, Ozempic, Cologuard Collection Kit, REXULTI, QULIPTA, Wegovy, SKYCLARYS, UBRELVY.
Industry payments across KY — which companies pay providers there.
